Truscreen Group Ltd

TRU

Company Profile

  • Business description

    Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.

  • Contact

    C/- HLB Mann Judd Limited
    57 Symonds Street
    Level 6, Equitable House
    Grafton
    Auckland1010
    NZL

    T: +64 93032243

    https://www.truscreen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2026

    Employees

    9

Stocks News & Analysis

stocks

BlackRock earnings: Market gains and inflows drive AUM and revenue to record highs

We plan to raise our fair value estimate of BlackRock stock.
stocks

Our view of ANZ’s strategic plan

Trying to please customers and shareholders with a simpler and leaner bank.
stocks

Perplexing buyback from overvalued ASX share

Earnings continue to grow but investor expectations are too high.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,271.605.50-0.06%
CAC 407,919.6214.64-0.18%
DAX 4024,236.94150.99-0.62%
Dow JONES (US)46,270.46202.880.44%
FTSE 1009,452.779.900.10%
HKSE25,714.89273.541.08%
NASDAQ22,521.70172.91-0.76%
Nikkei 22547,261.31413.990.88%
NZX 50 Index13,311.7034.710.26%
S&P 5006,644.3110.41-0.16%
S&P/ASX 2008,964.304.40-0.05%
SSE Composite Index3,864.930.30-0.01%

Market Movers